EC Number | Application | Comment | Organism |
---|---|---|---|
1.3.1.6 | medicine | aurones and auronols can be used as antiprotozoal compounds because the kill intracellularly persisting amastigozyte of Leishmania major by inhibiting respiratory function of parasite mitochondria | Leishmania major |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.6 | 2',6-dihydroxy-2-[phenylmethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 3',4',6-trihydroxy-2-[phenylmethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 3',6-dihydroxy-2-[phenylmethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 4',6-dihydroxy-2-[phenylmethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 4,6,3'-hydroxy-4'-methoxy-2-[phenylhydroxymethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 4,6,4'-hydroxy-3'-methoxy-2-[phenylhydroxymethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 4,6,4'-triacetyl-3',5'-dimethoxy-2-[phenylhydroxymethylene]-3(2H)-benzofuran-3-one | i.e. bracteintriacetate | Leishmania major | |
1.3.1.6 | 4,6-dihydroxy-2-[phenylhydroxymethylene]-3(2H)-benzofuran-3-ol | - |
Leishmania major | |
1.3.1.6 | 6-benzoyl-2-[phenylhydroxymethylene]-3(2H)-benzofuran-3-ol | - |
Leishmania major | |
1.3.1.6 | 6-hydroxy-2-[(2,3,4-trihydroxyphenyl)-methylene]-3(2H)-benzofuran-3-one-5-beta-D-glucopyranoside | i.e. bractein | Leishmania major | |
1.3.1.6 | 6-hydroxy-2-[phenylmethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 6-hydroxy-3',4'-dimethoxy-2-[phenylhydroxymethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 6-hydroxy-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | 6-methoxy-2-[phenylmethylene]-3(2H)-benzofuran-3-one | - |
Leishmania major | |
1.3.1.6 | additional information | inhibitory potency of aurones and auronols, overview | Leishmania major |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.3.1.6 | mitochondrion | - |
Leishmania major | 5739 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.6 | fumarate + NADH + H+ | Leishmania major | - |
succinate + NAD+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.6 | Leishmania major | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.3.1.6 | partially, preparation of the mitochondrial fraction | Leishmania major |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.6 | fumarate + NADH + H+ | - |
Leishmania major | succinate + NAD+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.3.1.6 | FRD | - |
Leishmania major |
1.3.1.6 | fumarate reductase | - |
Leishmania major |
1.3.1.6 | NADH-FRD | - |
Leishmania major |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.6 | NADH | - |
Leishmania major |